By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Noida, Uttar Pradesh, India <li /> To acquire R&D center at Saint-Julien-en-Genevois, France <li /> To add Drug Discovery & Preclin ...

In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.

"We are extremely pleased that the FDA granted Fast Track Designation to CUSP06," said Eric Slosberg, PhD, Chief Development Officer of OnCusp Therapeutics. "The early results from our Phase 1 trial ...

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

M&A in biotech and pharma is expected to surge in late 2024 as regulatory uncertainties ease. Discover trends, key players, and areas of high interest.

India’s Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to ...